NCT06669637Not yet recruiting
Amplify EP Registry
Source: ClinicalTrials.gov · Last updated 1 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
An observational, prospective, multi-center, non-randomized registry designed to obtain real world clinical experience with the TactiFlex Catheter Ablation system in the treatment of Atrial Fibrillation. Patient assessments will occur at pre procedure and procedure, and 1 year post ablation
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 1100 (estimated)
- First submitted
- 28 Oct 2024
- Start date
- 22 Nov 2024
- Primary completion date
- 31 May 2026
- Lead sponsor
- Heart Rhythm Clinical and Research Solutions, LLC
- Diseases
- Atrial fibrillation
- NCT number
- NCT06669637
What you commit to
- Study type: Observational
- Planned participants: 1100
- From 22 Nov 2024 to the primary completion date, 31 May 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Enrolled in any other cardiac device clinical trial, investigational drug trial, or any other trial that may confound the results of the ablation procedure.
- In the opinion of the investigator, any known contraindication to an ablation procedure or to any device or drug required for use during an ablation procedure as assessed by the investigator.
Who the study is looking for
- Patients who, in the opinion of the investigator, are candidates for ablation to treat atrial fibrillation.
- Plans to undergo an ablation procedure using the TactiFlex Ablation Catheter™, Sensor Enabled™ (TactiFlex SE) manufactured by Abbott.
- De Novo or redo AF catheter ablation procedures.
- Able and willing to participate in baseline and all follow up evaluations.
- 18 years of age or older.
Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.